An AllTrials project

NCT06072430: An ongoing trial by Vivacelle Bio

This trial is ongoing. It must report results 1 year from now.

Full data

Full entry on ClinicalTrials.gov NCT06072430
Title A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Aug. 6, 2024
Completion date Dec. 31, 2025
Required reporting date Dec. 31, 2026, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Dec. 12, 2025
Days late None